Accessibility Statement Skip Navigation
  • Resources
  • Investor Relations
  • Journalists
  • Agencies
  • Client Login
  • Send a Release
Return to PR Newswire homepage
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • All Public Company
      • English-only
      • News Releases Overview

      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
      • Multimedia Gallery Overview

      • Trending Topics

      • All Trending Topics
  • Business & Money
      • Auto & Transportation

      • All Automotive & Transportation
      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • Auto & Transportation Overview

      • View All Auto & Transportation

      • Business Technology

      • All Business Technology
      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • Business Technology Overview

      • View All Business Technology

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Financial Services & Investing

      • All Financial Services & Investing
      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • Financial Services & Investing Overview

      • View All Financial Services & Investing

      • General Business

      • All General Business
      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • General Business Overview

      • View All General Business

  • Science & Tech
      • Consumer Technology

      • All Consumer Technology
      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • Consumer Technology Overview

      • View All Consumer Technology

      • Energy & Natural Resources

      • All Energy
      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • Energy & Natural Resources Overview

      • View All Energy & Natural Resources

      • Environ­ment

      • All Environ­ment
      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • Environ­ment Overview

      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • All Heavy Industry & Manufacturing
      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • Heavy Industry & Manufacturing Overview

      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • All Telecomm­unications
      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • Telecomm­unications Overview

      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • All Consumer Products & Retail
      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • Consumer Products & Retail Overview

      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • All Entertain­ment & Media
      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • Entertain­ment & Media Overview

      • View All Entertain­ment & Media

      • Health

      • All Health
      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • Health Overview

      • View All Health

      • Sports

      • All Sports
      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • Sports Overview

      • View All Sports

      • Travel

      • All Travel
      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • Travel Overview

      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • All Policy & Public Interest
      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • Policy & Public Interest Overview

      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • All People & Culture
      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • People & Culture Overview

      • View All People & Culture

      • In-Language News

      • Arabic
      • español
      • português
      • Česko
      • Danmark
      • Deutschland
      • España
      • France
      • Italia
      • Nederland
      • Norge
      • Polska
      • Portugal
      • Россия
      • Slovensko
      • Suomi
      • Sverige
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • ALL CONTACT INFO
    • Contact Us

      888-776-0942
      from 8 AM - 10 PM ET

  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • News in Focus
    • Browse All News
    • Multimedia Gallery
    • Trending Topics
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices
  • Send a Release
  • Client Login
  • Resources
  • Blog
  • Journalists
  • RSS

New Data Reveals Too Few Young Americans Aware of the Real Dangers of Fentanyl, Even as Some Willing to Try Off-Script Medications that May Contain It


News provided by

Song for Charlie

Nov 02, 2022, 08:00 ET

Share this article

Share toX

Share this article

Share toX

Study commissioned by Song for Charlie underscores the great need to educate ages 13-24

PASADENA, Calif., Nov. 2, 2022 /PRNewswire/ -- About one in 10 teens and one in five young adults report having used prescription medicine off script, and a larger percentage have considered it, reveals a new study commissioned by Song for Charlie, the national family-run nonprofit charity dedicated to raising awareness about fake pills made from fentanyl. The top reasons described for using prescription medication off script for both teens and young adults were recreation and self-medication for stress and anxiety, as well as experimentation and image.

This important new data comes as the rate of drug deaths stemming from accidental poisoning among young Americans (ages 13-24) nearly doubled in the first year of the COVID-19 pandemic, and continued to rise by 20% to 7,500 in 2021. This tragic, all-time high is driven by the emergence of illicitly manufactured fentanyl in the drug supply, which is often made to look like legitimate prescription pills and sold deceptively to young people. 80% of these 7,500 deaths in 2021 involved fentanyl, higher than any other age group and up from 57% in 2018, making young Americans the fastest growing demographic of these deaths.

Roughly ten million counterfeit pills containing illicit fentanyl were seized in 2021, more than doubling in one year. These pills contain no actual pharmaceutical product, just inconsistent doses of illicit fentanyl and binding agents, with an estimated 40% of pills containing a potentially lethal dose. Professionals cannot tell real pills from the fake ones and they are marketed over social media directly to youth and passed between friends. The supply is increasingly toxic and deceptive.

This study, conducted by strategic communications and insights consultancy, Breakwater Strategy, was designed to explore young Americans' behaviors and attitudes regarding dangerous substances. This research being presented by Song for Charlie and Breakwater Strategy shows young Americans[NR1]  – defined as those ages 13-24 – recognize that using prescription medication without a doctor's prescription has risk, with about 60% of young adults and teens – defined as ages 13-17 – considering it very risky and about 30% considering it somewhat risky. But less than half of young Americans overall (48%), and barely ⅓ of teens (36%), are aware of the critical fact that fentanyl is being used to create counterfeit pills. Overall, only 40% of young Americans, including 31% of teens, consider themselves knowledgeable about fentanyl.

Just 68% of young Americans rate the danger of fentanyl as seven or higher on a 10-point scale, while 18% don't know enough to rate its danger. Among teens, 58% rate the danger of fentanyl as seven or higher on a 10-point scale while 26% can't rate it. Both young adults and teens rate fentanyl as just slightly more dangerous than real prescription opioids taken off script, and significantly more dangerous than stimulants like Adderall and benzodiazepines like Xanax. Meanwhile, substantially more – 80% – young Americans rate the dangers of heroin and cocaine as seven or higher on a 10-point scale. However, in 2021, deaths involving cocaine were five times fewer than those involving fentanyl, and heroin 10 times fewer. For teens, deaths with cocaine involved were 12 times fewer than those with fentanyl. This indicates the perception of harm is currently lethally inconsistent with reality.

As drug overdose rates grow ever more common, there is an urgent need to educate young Americans and the public at large on the dangers of fentanyl and counterfeit pills. Song for Charlie partners with experts, educators, parents, and other influencers to reach young audiences and educate them on the dangers of self-medication and to promote healthier mental health coping strategies.

"These findings underscore the importance of accelerating our work to educate young Americans about the dangers of fentapills," said Ed Ternan, president of Song for Charlie. "Like far too many families, we suffered an unspeakable loss because our son didn't know the pill he was buying was fake and could be deadly. Today, more young Americans understand that danger than they did last year - but millions remain at risk because they don't understand just how grave the consequences can be of taking a pill purchased from an illegitimate source. We're grateful to our partners that are getting the word out and we all must do more to arm kids with what they need most: truthful, reliable information."

Among young people, there is often significantly less knowledge of the dangers associated with pills than with other powerful substances like cocaine and heroin, and thus misusing prescription medications can be more socially acceptable among young people. 66% of young Americans know that people take prescription medication off script, 60% are aware of people their age doing it, and 45% know someone who has done so.

"This vital research will immediately inform our efforts to raise awareness of the dangers of fentanyl," said Courtney and Chris Chase, founders of the Sam Chase Fund, which helped fund this research. "Our partnership with Song for Charlie is helping us deliver the critical and relevant information we wish we had before our son Sam died of fentanyl poisoning in April 2020."

Young Americans say they would be most receptive to learning information about fentanyl through social media. 64% indicate they would be very or somewhat receptive to information about fentanyl from prominent individuals and influencers on social media, while three in five say the same about advertising and PSAs on social media.

"These results confirm our belief that social media has an important role to play in our awareness efforts," said Song for Charlie co-founder Mary Ternan. "We will continue to partner with the major platforms to reach kids where they are and speak to them in a relatable way."

Song for Charlie is continuing the fight against fentanyl-related deaths by using this research and other data-driven insights to develop and validate effective public awareness materials and campaigns, online and in the community. The results of this study help highlight the current landscape surrounding fentanyl and counterfeit pills, and identify tactics to reach those most vulnerable.

For the full set of survey questions and results across key audiences, please click here.

About Song for Charlie

Song for Charlie is a national family-run nonprofit charity dedicated to raising awareness about 'fentapills' — fake pills made of fentanyl. After the sudden loss of their son Charlie, Ed and Mary Ternan created Song for Charlie with one goal: to bring awareness to counterfeit prescription pills being sold online targeting young people. Song for Charlie partners with experts, educators, parents and other influencers to reach the most vulnerable group: young people between the ages 13-24. Its programs highlight the emerging dangers of self-medication and casual drug use in the fentanyl era and encourage healthier strategies for coping with stress. For more information, please visit songforcharlie.org.

About Breakwater Strategy

Breakwater Strategy is a strategic communications and insights agency that advises companies, brands, coalitions, and non-profits on how to navigate change, crises, and complexities. We have decades of experience in the halls of government, corporate boardrooms, and on the front lines of the issues and debates that have shaped our world. We tell you what you need to hear (not what you want to). We work with urgency and agility for clients wherever they are in the world.

About The Sam Chase Fund

The family-run Sam Chase Fund honors the memory of our beloved son and brother through a dual mission of connecting young adults with the resources they need to thrive and raising awareness of the dangers of fentanyl.

SOURCE Song for Charlie

WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?

icon3
440k+
Newsrooms &
Influencers
icon1
9k+
Digital Media
Outlets
icon2
270k+
Journalists
Opted In
GET STARTED

Modal title

Contact PR Newswire

  • Call PR Newswire at 888-776-0942
    from 8 AM - 9 PM ET
  • Chat with an Expert
  • General Inquiries
  • Editorial Bureaus
  • Partnerships
  • Media Inquiries
  • Worldwide Offices

Products

  • For Marketers
  • For Public Relations
  • For IR & Compliance
  • For Agency
  • All Products

About

  • About PR Newswire
  • About Cision
  • Become a Publishing Partner
  • Become a Channel Partner
  • Careers
  • Accessibility Statement
  • APAC
  • APAC - Simplified Chinese
  • APAC - Traditional Chinese
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Indonesia
  • Israel
  • Italy
  • Japan
  • Korea
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • Vietnam

My Services

  • All New Releases
  • Platform Login
  • ProfNet
  • Data Privacy

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact PR Newswire

Products

About

My Services
  • All News Releases
  • Platform Login
  • ProfNet
Call PR Newswire at
888-776-0942
  • Terms of Use
  • Privacy Policy
  • Information Security Policy
  • Site Map
  • RSS
  • Cookies
Copyright © 2025 Cision US Inc.